154 related articles for article (PubMed ID: 12637214)
1. New antileukemic agents.
Mantadakis E; Kalmanti M
Pediatr Hematol Oncol; 2003; 20(3):173-85. PubMed ID: 12637214
[TBL] [Abstract][Full Text] [Related]
2. New therapeutic strategies in acute lymphoblastic leukemia.
Jeha S
Semin Hematol; 2009 Jan; 46(1):76-88. PubMed ID: 19100370
[TBL] [Abstract][Full Text] [Related]
3. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
Pui CH; Jeha S
Nat Rev Drug Discov; 2007 Feb; 6(2):149-65. PubMed ID: 17268486
[TBL] [Abstract][Full Text] [Related]
4. Introduction: evolution of targeted and multifunctional agents for leukemias and lymphomas.
Tallman MS
Semin Hematol; 2008 Jul; 45(3 Suppl 2):S1. PubMed ID: 18760703
[No Abstract] [Full Text] [Related]
5. Angiogenesis inhibitors in the treatment of lung cancer.
Sun S; Schiller JH
Crit Rev Oncol Hematol; 2007 May; 62(2):93-104. PubMed ID: 17306557
[TBL] [Abstract][Full Text] [Related]
6. New nucleoside analogues in clinical development.
Faderl S; Gandhi V; Kantarjian H; Plunkett W
Cancer Chemother Biol Response Modif; 2002; 20():37-58. PubMed ID: 12703199
[No Abstract] [Full Text] [Related]
7. Developing targeted therapies for lung cancer.
Gandara DR
Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
[No Abstract] [Full Text] [Related]
8. Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases.
Mazitschek R; Giannis A
Curr Opin Chem Biol; 2004 Aug; 8(4):432-41. PubMed ID: 15288254
[TBL] [Abstract][Full Text] [Related]
9. Potential role of novel nucleoside analogs in the treatment of acute myeloid leukemia.
Faderl S; Gandhi V; Kantarjian HM
Curr Opin Hematol; 2008 Mar; 15(2):101-7. PubMed ID: 18300755
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors.
Newton HB
Curr Opin Investig Drugs; 2007 Dec; 8(12):1009-21. PubMed ID: 18058572
[TBL] [Abstract][Full Text] [Related]
11. New anticancer agents and therapeutic strategies in development for solid cancers: a clinical perspective.
Awada A; Mano M; Hendlisz A; Piccart M
Expert Rev Anticancer Ther; 2004 Feb; 4(1):53-60. PubMed ID: 14748657
[TBL] [Abstract][Full Text] [Related]
12. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
[TBL] [Abstract][Full Text] [Related]
13. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V;
Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892
[TBL] [Abstract][Full Text] [Related]
14. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for adult acute lymphoblastic leukaemia.
Thomas X
Expert Opin Emerg Drugs; 2005 Aug; 10(3):591-617. PubMed ID: 16083331
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents.
Holash J; Thurston G; Rudge JS; Yancopoulos GD; Adjei AA; Bergers G; Pytowski B; Pegram M; Gordon MS
Cancer Metastasis Rev; 2006 Jun; 25(2):243-52. PubMed ID: 16770536
[No Abstract] [Full Text] [Related]
17. A new smart way to treat cancer.
Johns Hopkins Med Lett Health After 50; 2003 Oct; 15(8):1-2, 7. PubMed ID: 14619801
[No Abstract] [Full Text] [Related]
18. Rituximab as therapy for acute lymphoblastic leukemia.
Thomas DA
Clin Adv Hematol Oncol; 2010 Mar; 8(3):168-71. PubMed ID: 20400931
[No Abstract] [Full Text] [Related]
19. Angiogenesis inhibitors in cancer therapy.
Dredge K; Dalgleish AG; Marriott JB
Curr Opin Investig Drugs; 2003 Jun; 4(6):667-74. PubMed ID: 12901224
[TBL] [Abstract][Full Text] [Related]
20. New agents in the treatment of acute lymphocytic leukaemia.
Thomas DA; Cortes J; Kantarjian HM
Best Pract Res Clin Haematol; 2002 Dec; 15(4):771-90. PubMed ID: 12617876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
